Francesca M Dimou1, Deepak Adhikari2, Hemalkumar B Mehta2, Taylor S Riall3. 1. Department of Surgery, The University of Texas Medical Branch, Galveston, TX; Department of Surgery, University of South Florida, Tampa, FL. 2. Department of Surgery, The University of Texas Medical Branch, Galveston, TX. 3. Department of Surgery, The University of Texas Medical Branch, Galveston, TX; Department of Surgery, University of Arizona, Tucson, AZ. Electronic address: tsriall@surgery.arizona.edu.
Abstract
BACKGROUND: The Tokyo Guidelines recommend initial cholecystostomy tube drainage, antibiotics, and delayed cholecystectomy in patients with grade III cholecystitis. STUDY DESIGN: We used Medicare data (1996 to 2010) to identify patients 66 years and older who were admitted with grade III acute cholecystitis. We evaluated adherence to the Tokyo Guidelines and compared mortality, readmission, and complication rates with and without cholecystostomy tube placement in a propensity-matched (1:3) cohort of patients with grade III cholecystitis. RESULTS: There were 8,818 patients admitted with grade III cholecystitis; 565 patients (6.4%) had a cholecystostomy tube placed. Cholecystostomy tube placement increased from 3.9% to 9.7% during the study period. Compared with 1,689 propensity-matched controls, patients with cholecystostomy tube placement had higher 30-day (hazard ratio [HR] = 1.26; 95% CI 1.05 to 1.50), 90-day (HR = 1.26; 95% CI 1.08 to 1.46), and 2-year mortality (HR = 1.19; 95% CI 1.04 to 1.36) and were less likely to undergo cholecystectomy in the 2 years after initial hospitalization (33.4% vs 64.4%; HR = 0.26; 95% CI 0.21 to 0.31). Readmissions were also higher at 30 days (HR = 2.93; 95% CI 2.12 to 4.05), 90 days (HR = 3.48; 95% CI 2.60 to 4.64), and 2 years (HR = 3.08; 95% CI 2.87 to 4.90). CONCLUSIONS: Since the introduction of the Tokyo Guidelines (2007), use of cholecystostomy tubes in patients with grade III cholecystitis has increased, but the majority of patients do not get cholecystostomy tube drainage as first-line therapy. Cholecystostomy tube placement was associated with lower rates of definitive treatment with cholecystectomy, higher mortality, and higher readmission rates. These data suggest a need for additional evaluation and refinement of the Tokyo Guidelines.
BACKGROUND: The Tokyo Guidelines recommend initial cholecystostomy tube drainage, antibiotics, and delayed cholecystectomy in patients with grade III cholecystitis. STUDY DESIGN: We used Medicare data (1996 to 2010) to identify patients 66 years and older who were admitted with grade III acute cholecystitis. We evaluated adherence to the Tokyo Guidelines and compared mortality, readmission, and complication rates with and without cholecystostomy tube placement in a propensity-matched (1:3) cohort of patients with grade III cholecystitis. RESULTS: There were 8,818 patients admitted with grade III cholecystitis; 565 patients (6.4%) had a cholecystostomy tube placed. Cholecystostomy tube placement increased from 3.9% to 9.7% during the study period. Compared with 1,689 propensity-matched controls, patients with cholecystostomy tube placement had higher 30-day (hazard ratio [HR] = 1.26; 95% CI 1.05 to 1.50), 90-day (HR = 1.26; 95% CI 1.08 to 1.46), and 2-year mortality (HR = 1.19; 95% CI 1.04 to 1.36) and were less likely to undergo cholecystectomy in the 2 years after initial hospitalization (33.4% vs 64.4%; HR = 0.26; 95% CI 0.21 to 0.31). Readmissions were also higher at 30 days (HR = 2.93; 95% CI 2.12 to 4.05), 90 days (HR = 3.48; 95% CI 2.60 to 4.64), and 2 years (HR = 3.08; 95% CI 2.87 to 4.90). CONCLUSIONS: Since the introduction of the Tokyo Guidelines (2007), use of cholecystostomy tubes in patients with grade III cholecystitis has increased, but the majority of patients do not get cholecystostomy tube drainage as first-line therapy. Cholecystostomy tube placement was associated with lower rates of definitive treatment with cholecystectomy, higher mortality, and higher readmission rates. These data suggest a need for additional evaluation and refinement of the Tokyo Guidelines.
Authors: Byung Hyo Cha; Ha Hun Song; Young Nam Kim; Won Jung Jeon; Sang Jin Lee; Jin Dong Kim; Hak Hyun Lee; Ban Seok Lee; Sang Hyub Lee Journal: Korean J Gastroenterol Date: 2014-01-25
Authors: Ye Rim Chang; Young-Joon Ahn; Jin-Young Jang; Mee Joo Kang; Wooil Kwon; Woo Hyun Jung; Sun-Whe Kim Journal: Surgery Date: 2014-01-11 Impact factor: 3.982
Authors: Michael F Byrne; Paul Suhocki; Robert M Mitchell; Theodore N Pappas; Helen L Stiffler; Paul S Jowell; Malcolm S Branch; John Baillie Journal: J Am Coll Surg Date: 2003-08 Impact factor: 6.113
Authors: Mehrdad Nikfarjam; Lilly Shen; Michael A Fink; Vijayaragavan Muralidharan; Graham Starkey; Robert M Jones; Christopher Christophi Journal: Surg Laparosc Endosc Percutan Tech Date: 2013-10 Impact factor: 1.719
Authors: Adam A Hatzidakis; Panos Prassopoulos; Ioannis Petinarakis; Elias Sanidas; Emmanuel Chrysos; Georgios Chalkiadakis; Dimitrios Tsiftsis; Nicholas C Gourtsoyiannis Journal: Eur Radiol Date: 2002-02-21 Impact factor: 5.315
Authors: E Atar; G N Bachar; S Berlin; C Neiman; E Bleich-Belenky; S Litvin; M Knihznik; A Belenky; E Ram Journal: Clin Radiol Date: 2014-03-01 Impact factor: 2.350
Authors: Tyler J Loftus; Elisha M Collins; Camille G Dessaigne; Amber N Himmler; Alicia M Mohr; Ryan M Thomas; Charles E Hobson; George A Sarosi; William J Zingarelli Journal: Surg Endosc Date: 2017-04-13 Impact factor: 4.584